glp-1 news 2025 november Agonists Weight Loss Drugs Market Report, 2025-2030 GLP-1 weight loss medications no

Despite this, no increase in heart attacks or serious heart problems has been reported so far

Gastrointestinal symptoms like nausea and vomiting are the primary reported effects

Extending the findings from the UK cohort study, additional real-world data derived from the Taiwan National Health Insurance Databasewhich encompasses Asian populations characterized by lower gallstone prevalence, low-fat and high-fiber dietary patterns, and lower body mass indexalso documented an elevated risk of biliary-related diseases linked to GLP-1 RAs compared with SGLT-2 inhibitors [36]

But there's a catchand one unlikely to surprise anyone familiar with the U.S